Global Micro-Invasive Glaucoma Surgery (MIGS) Devices Market Analysis and Forecast 2022 by Size, Share and Growth Rate
www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Micro-Invasive Glaucoma Surgery Market on the basis of Target (Trabecular Meshwork, Suprachoroidal Space), By Surgery (Glaucoma in conjunction with Cataract and Stand Alone Glaucoma), By End User (Hospital Outpatient Departments - HOPDs and Ambulatory Surgery Centers - ASCs), By Region (North America, Europe, APAC and ROW) and By Country (U.S., Canada, U.K., Germany, France, Japan, South Korea, Australia, Brazil and South Africa). Browse the report: http://www.orbisresearch.com/reports/index/global-micro-invasiveglaucoma-surgery-migs-devices-market-by-target-by-surgery-by-end-user-by-region-by-countryopportunities-and-forecast-2017-2022 Over the recent years, the global Micro-Invasive Glaucoma Surgery industry has been growing rapidly as the global sales of iStent device by Glaukos which was the only commercially available device in United States has witnessed rapid growth post its FDA approval in 2012. Globally, the growth in micro-invasive glaucoma surgery device market is driven by several MIGS devices entering the market in next five years, rising number of glaucoma patients and rapidly aging population. According to Azoth Analytics research report, “Global Micro-Invasive Glaucoma Surgery (MIGS) Devices Market (By Target, By Surgery, By End User, By Region, By Country): Opportunities and Forecast (2017-2022) - By Target (Trabecular Meshwork, Suprachoroidal Space), By Surgery (Glaucoma – Cataract, Standalone), By End User (HOPD, ASCs), By Region (N. America, Europe, APAC, ROW), By Country (U.S., Canada, U.K., Germany, France, Japan, South Korea, Australia, Brazil, South Africa)”, global market is projected to display a robust growth represented by a CAGR of 47.10% during 2017 – 2022, chiefly driven by several MIGS devices entering the market in next five years, rising number of glaucoma patients and rapidly aging population, high safety profile and reduced dependency on prescription eye drops. Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/299158 Among the targets, Trabecular Meshwork currently dominates the Micro-Invasive Glaucoma Surgery market. Among the surgeries, Stand Alone Glaucoma surgery is projected to witness fastest growth. In terms of End User, Ambulatory Surgery Centers is predicted to grow at a higher rate than HOPDs (Hospital Outpatient Departments). Among the regions, Asia Pacific is predicted to advance at the highest rate, mainly driven by large glaucoma population and expansion of MIGS device in the region. The report titled, “Global Micro-Invasive Glaucoma Surgery (MIGS) Devices Market (By Target, By Surgery, By End User, By Region, By Country): Opportunities and Forecast (20172022) - By Target (Trabecular Meshwork, Suprachoroidal Space), By Surgery (Glaucoma – Cataract, Standalone), By End User (HOPD, ASCs), By Region (N. America, Europe, APAC, www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019
ROW), By Country (U.S., Canada, U.K., Germany, France, Japan, South Korea, Australia, Brazil, South Africa)”, has covered and analyzed the potential of Global Micro-Invasive Glaucoma Surgery Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global food service equipment market. Additionally, the report also highlights market entry strategies for various companies across the globe. Scope of the Report Global Market (Actual Period: 2013-2016, Forecast Period: 2017-2022) Micro-Invasive Glaucoma Surgery Market Global MIGS Device Market, By Target (Trabecular Meshwork, Suprachoroidal Space, Others) Global MIGS Device Market, By Surgery (Glaucoma in Conjunction with Cataract, Stand Alone Glaucoma) Global MIGS Device Market, By End User (Hospital Outpatient Departments, Ambulatory Surgery Centers) Regional Markets – N. America, Europe, APAC, ROW (Actual Period: 2012-2016, Forecast Period: 2017-2022) Micro-Invasive Glaucoma Surgery Market Global MIGS Device Market, By Target Global MIGS Device Market, By Surgery Global MIGS Device Market, By End User Country Analysis - US, Canada, UK, Germany, France, Japan, South Korea, Australia, Brazil, South Africa (Actual Period: 2012-2016, Forecast Period: 2017-2022) Micro-Invasive Glaucoma Surgery Market Global MIGS Device Market, By Surgery in Percentage (2016, 2022) Global MIGS Device Market, By End User in Percentage (2016, 2022) Other Report Highlights Market Dynamics – Trends, Drivers, Challenges Policy and Regulation Company Analysis – Glaukos, Alcon, Santen, Ivantis, Allergan Customization of the Report The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research. About Us: Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019
the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients. Contact Information: Hector Costello Senior Manager – Client Engagements 4144N Central Expressway, Suite 600, Dallas, Texas – 75204, U.S.A. Phone No.: +1 (214) 884-6817; +9164101019 Email: sales@orbisresearch.com
www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019